Rapid modifications of peripheral T-cell subsets that express CD127 in macaques treated with recombinant IL-7

Journal of Medical Primatology

Volumn 36, Issue 4-5, 2007, Pages 228-237

  Dereuddre Bosquet, Nathalie ^a   Vaslin, Bruno ^a   Delache, Benoit ^a   Brochard, Patricia ^a   Clayette, Pascal ^a   Aubenque, Céline ^a   Morre, Michel ^b   Assouline, Brigitte ^b   Le Grand, Roger ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b Cytheris SA   (France)

Author keywords

CD127; Cynomolgus macaque; Recombinant simian interleukin 7

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 7 RECEPTOR; KI 67 ANTIGEN; PROTEIN BCL 2; RECOMBINANT INTERLEUKIN 7;

ALPHA CHAIN; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; AREA UNDER THE CURVE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG TOLERABILITY; LYMPHOCYTE COUNT; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TIME;

MACACA; SIMIAE;

EID: 34547118143     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2007.00240.x     Document Type: Conference Paper

References (34)

1. Beq S, Delfraissy JF, Theze J: Interleukin-7 (IL-7) immune function, involvement in the pathogenesis of HIV infection and therapeutic potential. Eur Cytokine Netw 2004; 15: 279-89.
2. Beq S, Nugeyre MT, Ho.Tsong.Fang R, Gautier D, Legrand R, Schmitt N, Estaquier J, Barre-Sinoussi F, Hurtrel B, Cheynier R, Israel N: IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy. J Immunol 2006; 176: 914-22.
3. Borger P, Kauffman HF, Postma DS, Vellenga E: IL-7 differentially modulates the expression of IFN-gamma and IL-4 in activated human T lymphocytes by transcriptional and post-transcriptional mechanisms. J Immunol 1996; 156: 1333-8.
4. Chen HW, Liao CH, Ying C, Chang CJ, Lin CM: Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ cells with anti-CD3/CD28, interleukin-7, and interleukin-15: Potential for adoptive T cell immunotherapy. Clin Immunol 2006; 119: 21-31.
5. Cohan OJ, Fauchi AS: Current strategies in the treatment of HIV infection. Adv Intern Med 2001; 46: 207 -46.
6. Fry TJ, MFckall CL: Interleukin-7: from bench to clinic. Blood 2002; 99: 3892-904.
7. Fry TJ, Mackall CLF The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J Immunol 2005; 174: 6571-6.
8. Fry TJ, Moniuszko M, Creekmore S, Donohue SJ, Douek DC, Giardina S, Hecht TT, Hill BJ, Komschlies K, Tomaszewski J, Franchini G, Mackall CL: IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. Blood 2003; 101: 2294-9.
9. Hryniewicz A, Price DA, Moniuszko M, Boasso A, Edghill-Spano Y, West SM, Venzon D, Vaccari M, Tsai WP, Tryniszewska E, Nacsa J, Villinger F, Ansari AA, Trindade CJ, Morre M, Brooks D, Arlen P, Brown HJ, Kitchen CM, Zack JA, Douek DC, Shearer GM, Lewis MG, Koup RA, Frnchini G: Interleukin-15 but not interleukin-7 abrogates vaccine-induced decrease in virus level in simian immunodeficiency virus mac251-infected macaques. J Immunol 2007; 178: 3492-504.
10. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R: Selective expression of the interleukin 7 receptor identifies effctor CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003; 4: 1191-8.
11. Kovacs JA, Vogel S, Albert JM, Fallon J, Davey Jr., RT, Walker RE, Polis MA, Spooner K, Metcalf JA, Baseler M, Fyfe G, Lane HC: Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus. N Engl J Med 1996; 335: 1350-6.
12. Lange CG, Lederman MM: Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 2003; 51: 1-4.
13. Lange CG, Xu Z, Patterson BK, Medvik K, Harnisch B, Asaad R, Valdez H, Lee SJ, Landay A, Lieberman J, Lederman MM: Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS 2004; 18: 605-13.
14. Lederman MM: Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS 2001; 15 Suppl 2: S11-5.
15. Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C, Gastaut JA, Oksenhendler E, Boumsell L, Gomard E, Rabian C, Weiss L, Guillet JG, Delfraissy JF, Aboulker JP, Seligmann M: Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: A randomized controlled trial. ANRS 048 study group. Lancet 1999; 353: 1923-9.
16. Levy Y, Durier C, Krzysiek R, Rabian C, Capitant C, Lascaux AS, Michon C, Oksenhendler E, Weiss L, Gastaut JA, Goujard C, Rouzioux C, Maral J, Delfraissy JF, Emilie D, Aboulker JP: Effects of interleukin-2 therapy combined with highly active antretroviral therapy on immune restoration in HIV-1 infection: A randomized controlled trail. AIDS 2003; 17: 343-51.
17. Li B, Vanroey MJ, Jooss K: Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy. Clin Immunol 2007; 123: 155-65.
18. Lynch DH, Namen AE, Miller RE: In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes. Eur J Immunol 1991; 21: 2977-85.
19. Mehrotra PT, Grant AJ, Siegel JP: Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995; 154: 5093-102.
20. Melchionda F, Fry TJ, Milliron MJ, McKirdy MA, Tagaya Y, Mackall CL: Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool. J Clin Invest 2005; 115: 1177-87.
21. Moniuszko M, Edghill-Smith Y, Venzon D, Stevceva L, Nacsa J, Tryniszewska E, Tsai WP, Franchini G: Decreased number of CD4(+) and CD8(+) T cells that express the interleukin-7 receptor in blood and tissues of SIV-infected macaques. Virology 2006; 356: 188-97.
22. Moniuszko M, Fry T, Tsai WP, Morre M, Assouline B, Cortez P, Lewis MG, Caims S, Mackall C, Franchini G. Recombinant interleukin-7 induces proliferation of naive macaque CD4+ and CD8+ T cells in vivo. J Virol 2004; 78: 9740-9.
23. Naume B, Espevik T: Effects of IL-7 and IL-2 on highly enriched CD56+ natural killer cells. A comparative study. J Immunol 1991; 147: 2208-14.
24. Nugeyre MT, Monceaux V, Beq S, Cumont MC, Ho.Tsong.Fang R, Chene L, Morre M, Barre-Sinoussi F, Hurtrel B, Israel N: IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques. J Immunol 2003; 171: 4447-53.
25. Rosenberg SA, Sportes C, Ahmadzadeh M, Fry TJ, Ngo LT, Schwarz SL, Stetler-Stevenson M, Morton KE, Mavroukakis SA, Morre M, Buffet R, Mackall CL, Gress RE: IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J. Immunother 2006; 29: 313-9.
26. Schluns KS, Lefrancois L: Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3: 269-79.
27. Seddon B, Tomlinson P, Zamoyska R: Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4: 680-6.
28. Snyder KM, Mackall CL, FrC TJ: IL-7 in allogeneic transplant: clinical promise and potential pitfalls. Leuk Lymphoma, 2006; 47: 1222-8.
29. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, Surh CD: IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98: 8732-7.
30. Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD: Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med 2002; 195: 1523-32.
31. Valdez H, Connick E, Smith KY, Lederman MM, Bosch RJ, Kim RS, St.Clair M, Kuritzkes DR, Kessler H, Fox L, Blanchard-Varges M, Landay A: Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease. AIDS 2002; 16: 1859-66.
32. Valdez H, Lederman MM: Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev, 1997; 187-228.
33. Wood E, Hogg RS, Harrigan PR, Montaner JS: When to initiate antiretroviral therapy in HIV-1-infected adults: A review for clinicians and patients. Lancet Infect Dis 2005; 5: 407-14.
34. Wood E, Hogg RS, Yip B, Dong WW, Wynhoven B, Mo T, Brumme CJ, Montaner JS, Harrigan PR: Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use. AIDS 2005; 19: 1189-95.